Advertisement
Research Article

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis

  • Friedemann Paul equal contributor,

    equal contributor Contributed equally to this work with: Friedemann Paul, Sonia Waiczies, Jens Wuerfel

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Sonia Waiczies equal contributor,

    equal contributor Contributed equally to this work with: Friedemann Paul, Sonia Waiczies, Jens Wuerfel

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Jens Wuerfel equal contributor,

    equal contributor Contributed equally to this work with: Friedemann Paul, Sonia Waiczies, Jens Wuerfel

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Judith Bellmann-Strobl,

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Jan Dörr,

    Affiliations: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Department of Neurology in the HELIOS Clinic Berlin-Buch, Berlin, Germany

    X
  • Helmar Waiczies,

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Mareile Haertle,

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    X
  • Klaus D. Wernecke,

    Affiliation: Sostana, Department of Medical Statistics, Berlin, Germany

    X
  • Hans-Dieter Volk,

    Affiliation: Institute of Immunology, Charité – University Medicine Berlin, Berlin, Germany

    X
  • Orhan Aktas ,

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    These authors also contributed equally to this work.

    X
  • Frauke Zipp mail

    frauke.zipp@charite.de

    Affiliation: Cecilie Vogt Clinic for Neurology in the HELIOS Clinic Berlin-Buch, Charité – University Medicine Berlin and Max-Delbrueck Center for Molecular Medicine, Berlin, Germany

    These authors also contributed equally to this work.

    X
  • Published: April 09, 2008
  • DOI: 10.1371/journal.pone.0001928

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.